Donald C. Porter

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics”.

A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.1c01951

N/A

0DataRank · unranked

38 citations

Chen Cheng, Jing Li, Lili Wang, Alexander A. Chumanevich, Donald C. Porter +6 more

CDK19 and CDK8 Mediator kinases drive androgen-independent in vivo growth of castration-resistant prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.08.552491

N/A

0DataRank · unranked

2 citations

Thomas A. Hilimire, Yueying Liu, Lili Wang, Jiaxin Liang, Balázs Győrffy +19 more

Mediator kinase inhibition reverses castration resistance of advanced prostate cancer

Journal of Clinical Investigation(2024)10.1172/jci176709

N/A

0DataRank · unranked

22 citations

Thomas A. Hilimire, Yueying Liu, Lili Wang, Jiaxin Liang, Balázs Győrffy +21 more